companydata.dkAVILEX PHARMA ApS: Financial statements 2018
CVR: 34896828
AVILEX PHARMA ApS (CVR 34896828) has filed annual accounts for 2018. In 2018, the company reported a net result of DKK -3,860,576 compared with DKK -2,415,685 the year before. Equity amounted to DKK -11,881,155. The company had 1 employee in the financial year.
- Profit/Loss
- -3,860,576 kr.
- Equity
- -11,881,155 kr.
- Total Assets
- 6,748,830 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | - | -3.9 mio. | -11.9 mio. | 1 |
| 2017 | - | - | -2.4 mio. | -8.1 mio. | 1 |
| 2016 | - | - | -5.5 mio. | -5.7 mio. | 1 |
| 2015 | - | - | -7.6 mio. | -279 t. | 3 |
| 2014 | - | - | -1.2 mio. | -4.1 mio. | 0 |
Keep an eye on AVILEX PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
As of December 21, 2018, Morten Døssing has joined the board of directors of AVILEX PHARMA ApS.
As of December 21, 2018, Emmanuelle Coutanceau has left the board of directors of AVILEX PHARMA ApS.
AVILEX PHARMA ApS has published its annual report for 2017. The net result was DKK -2,415,685.
As of May 1, 2018, Jonathan Mark Treherne has joined the board of directors of AVILEX PHARMA ApS.
As of May 1, 2018, Jonathan Mark Treherne has stepped down as adm. dir. of AVILEX PHARMA ApS.
About AVILEX PHARMA ApS
AVILEX PHARMA ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kristian Strømgaard. The company's owners include Novo Holdings A/S, MIKAEL SØNDERGÅRD THOMSEN ApS and KRISTIAN STRØMGAARD HOLDING ApS. The company has 3 employees. In 2024, the company reported a net result of DKK -4,428,000 compared with DKK -6,756,000 the year before. Equity amounted to DKK -6,267,000.